Molecular Pituitary Imaging Using 18F-FET PET
ConditionPituitary Adenoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Cambridge
About this trial
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
Eligibility criteria
Qualifiers
Participant is willing and able to give informed consent for participation in the study
Male or female, age 18 or above
Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings
Previous 11C-Met-PET/CT
Disqualifiers
Inability to give informed consent
Pregnancy or suspected pregnancy
Inability to lie supine for 30-60 minutes
Patient body habitus above scanner dimensions
Trial design
Treatments tested in this trial
- 18F-Fluoro-ethyl-tyrosine (FET) PET
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Cambridge
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Collaborator
Source ClinicalTrials.gov